Health Canada Authorizes Moderna’s Bivalent Covid Booster Dose For People Aged 18 And Older
- Reuters Citing Government Website
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna.html
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization For Use Of Moderna’s Omicron-Targeting Bivalent Booster In The European Union
Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 subvariants when compared with mRNA-1273
Positive recommendation follows recent amendment to
Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use of its Omicron-tar
Moderna Receives FDA Authorization For Emergency Use Of Omicron-Targeting Bivalent COVID-19 Booster Vaccine For Adults 18 Years And Older
Moderna's Bivalent Booster Shots to be Available Nationwide In Coming Days
mRNA-1273.222 Targets BA.4/.5 Strains of Omicron Variant
CAMBRIDGE, MA / ACCESSWIRE / August 31, 2022 / Moderna, Inc. (NASDAQ:MRNA), a
Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib)…